Rohde R - Search Results

1

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I; Collaborative Study Group. Lewis EJ, et al. Among authors: rohde r. N Engl J Med. 2001 Sep 20;345(12):851-60. doi: 10.1056/NEJMoa011303. N Engl J Med. 2001. PMID: 11565517 Free article. Clinical Trial.

2

Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial.

Lewis EJ, Lewis JB, Greene T, Hunsicker LG, Berl T, Pohl MA, de Zeeuw D, Heerspink HL, Rohde RD, Atkins RC, Reutens AT, Packham DK, Raz I; Collaborative Study Group. Lewis EJ, et al. Am J Kidney Dis. 2011 Nov;58(5):729-36. doi: 10.1053/j.ajkd.2011.06.020. Epub 2011 Aug 26. Am J Kidney Dis. 2011. PMID: 21872376 Clinical Trial.

3

Pyridorin in type 2 diabetic nephropathy.

Lewis EJ, Greene T, Spitalewiz S, Blumenthal S, Berl T, Hunsicker LG, Pohl MA, Rohde RD, Raz I, Yerushalmy Y, Yagil Y, Herskovits T, Atkins RC, Reutens AT, Packham DK, Lewis JB; Collaborative Study Group. Lewis EJ, et al. J Am Soc Nephrol. 2012 Jan;23(1):131-6. doi: 10.1681/ASN.2011030272. Epub 2011 Oct 27. J Am Soc Nephrol. 2012. PMID: 22034637 Free PMC article. Clinical Trial.

4

A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.

Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM. Lewis EJ, et al. Among authors: rohde rd. N Engl J Med. 1992 May 21;326(21):1373-9. doi: 10.1056/NEJM199205213262101. N Engl J Med. 1992. PMID: 1569973 Free article. Clinical Trial.

5

The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy. The Collaborative Study Group.

Rodby RA, Rohde RD, Sharon Z, Pohl MA, Bain RP, Lewis EJ. Rodby RA, et al. Among authors: rohde rd. Am J Kidney Dis. 1995 Dec;26(6):904-9. doi: 10.1016/0272-6386(95)90054-3. Am J Kidney Dis. 1995. PMID: 7503064 Clinical Trial.

6

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. Lewis EJ, et al. Among authors: rohde rd. N Engl J Med. 1993 Nov 11;329(20):1456-62. doi: 10.1056/NEJM199311113292004. N Engl J Med. 1993. PMID: 8413456 Free article. Clinical Trial.

7

The Irbesartan type II diabetic nephropathy trial: study design and baseline patient characteristics. For the Collaborative Study Group.

Rodby RA, Rohde RD, Clarke WR, Hunsicker LG, Anzalone DA, Atkins RC, Ritz E, Lewis EJ. Rodby RA, et al. Among authors: rohde rd. Nephrol Dial Transplant. 2000 Apr;15(4):487-97. doi: 10.1093/ndt/15.4.487. Nephrol Dial Transplant. 2000. PMID: 10727543 Clinical Trial.

8

A controlled clinical trial of angiotensin-converting enzyme inhibition in type I diabetic nephropathy: study design and patient characteristics. The Collaborative Study Group.

Bain R, Rohde R, Hunsicker LG, McGill J, Kobrin S, Lewis EJ. Bain R, et al. Among authors: rohde r. J Am Soc Nephrol. 1992 Oct;3(4 Suppl):S97-103. doi: 10.1681/ASN.V34s97. J Am Soc Nephrol. 1992. PMID: 1457767 Clinical Trial.

9

Serum levels of the advanced glycation end products Nepsilon-carboxymethyllysine and pentosidine are not influenced by treatment with the angiotensin receptor II type 1 blocker irbesartan in patients with type 2 diabetic nephropathy and hypertension.

Busch M, Franke S, Wolf G, Rohde RD, Stein G; Collaborative Study Group. Busch M, et al. Nephron Clin Pract. 2008;108(4):c291-7. doi: 10.1159/000127838. Epub 2008 Apr 24. Nephron Clin Pract. 2008. PMID: 18434751 Clinical Trial.

10

Renal scanning 99mTc diethylene-triamine pentaacetic acid glomerular filtration rate (GFR) determination compared with iothalamate clearance GFR in diabetics. The Collaborative Study Group for The study of Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy.

Rodby RA, Ali A, Rohde RD, Lewis EJ. Rodby RA, et al. Among authors: rohde rd. Am J Kidney Dis. 1992 Dec;20(6):569-73. doi: 10.1016/s0272-6386(12)70220-2. Am J Kidney Dis. 1992. PMID: 1462984 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

308 results

Search Page